LPS-induced MCP-1 Expression in Human Microvascular Endothelial Cells is Mediated by the Tyrosine Kinase, Pyk2 Via the P38 MAPK/NF-kappaB-dependent Pathway

Overview

Journal Mol Immunol

Specialties Allergy & Immunology
Molecular Biology

Date 2008 Oct 29

PMID 18954908

Citations 27

Authors

Appakkudal R Anand

Ritu Bradley

Ramesh K Ganju

Affiliations

Soon will be listed here.

Abstract

Bacterial endotoxin (lipopolysaccharide or LPS) has potent pro-inflammatory properties and acts on many cell types including endothelial cells. Secretion of the CC chemokine, MCP-1 (CCL2) by LPS-activated endothelial cells contributes substantially to the pathogenesis of sepsis. However, the mechanism involved in LPS-induced MCP-1 production in endothelial cells is not well understood. Using human microvascular endothelial cells (HMVEC), we analyzed the involvement of the non-receptor tyrosine kinase, Pyk2, in LPS-mediated MCP-1 production. There was a marked activation of the non-receptor tyrosine kinase, Pyk2, in response to LPS. Inhibition of Pyk2 activity using a pharmacological inhibitor, Tyrphostin A9 significantly attenuated LPS-induced Pyk2 tyrosine phosphorylation, p38 MAP kinase (MAPK) activation, NF-kappaB activation, and MCP-1 expression. Furthermore, specific inactivation of Pyk2 activity by transducing microvascular endothelial cells with catalytically inactive Pyk2 mutant (AAV-Pyk2MT) or Pyk2-specific siRNA significantly blocked LPS-induced MCP-1 production. The supernatants of these LPS-stimulated cells with attenuated Pyk2 activity demonstrated decreased trans-endothelial monocyte migration in comparison to LPS-treated controls, thus confirming the inhibition of functional MCP-1 production. In summary, our data suggest a critical role for the Pyk2 mediated pathway involving p38 MAP kinase and NF-kappaB in LPS-induced MCP-1 production in human microvascular endothelial cells.

Citing Articles

Pyk2/FAK Signaling Is Upregulated in Recurrent Glioblastoma Tumors in a C57BL/6/GL261 Glioma Implantation Model.

Ortiz Rivera J, Velez Crespo G, Inyushin M, Kucheryavykh Y, Kucheryavykh L Int J Mol Sci. 2023; 24(17).

PMID: 37686276 PMC: 10487692. DOI: 10.3390/ijms241713467.

The Impacts of Animal-Based Diets in Cardiovascular Disease Development: A Cellular and Physiological Overview.

Najjar R J Cardiovasc Dev Dis. 2023; 10(7).

PMID: 37504538 PMC: 10380617. DOI: 10.3390/jcdd10070282.

Serratiopeptidase Attenuates -Induced Vascular Inflammation by Inhibiting the Expression of Monocyte Chemoattractant Protein-1.

Yadav V, Sharma S, Kumar A, Singh S, Ravichandiran V Curr Issues Mol Biol. 2023; 45(3):2201-2212.

PMID: 36975512 PMC: 10047379. DOI: 10.3390/cimb45030142.

Therapeutic Targeting of NF-κB in Acute Lung Injury: A Double-Edged Sword.

Millar M, Fazal F, Rahman A Cells. 2022; 11(20).

PMID: 36291185 PMC: 9601210. DOI: 10.3390/cells11203317.

Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice.

Alves G, Aimaretti E, Einaudi G, Mastrocola R, de Oliveira J, Collotta D Front Immunol. 2022; 13:837180.

PMID: 35178052 PMC: 8843946. DOI: 10.3389/fimmu.2022.837180.

References

Anand A, Cucchiarini M, Terwilliger E, Ganju R . The tyrosine kinase Pyk2 mediates lipopolysaccharide-induced IL-8 expression in human endothelial cells. J Immunol. 2008; 180(8):5636-44. PMC: 4117313. DOI: 10.4049/jimmunol.180.8.5636. View

Hack C, Zeerleder S . The endothelium in sepsis: source of and a target for inflammation. Crit Care Med. 2001; 29(7 Suppl):S21-7. DOI: 10.1097/00003246-200107001-00011. View

Beck G, Yard B, Breedijk A, van Ackern K, van der Woude F . Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin Exp Immunol. 1999; 118(2):298-303. PMC: 1905420. DOI: 10.1046/j.1365-2249.1999.01052.x. View

Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk H . MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol. 1999; 1(2):94-7. DOI: 10.1038/10061. View

Adams J, Badger A, Kumar S, Lee J . p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. Prog Med Chem. 2002; 38:1-60. DOI: 10.1016/s0079-6468(08)70091-2. View

Keogh R, Houliston R, Wheeler-Jones C . Human endothelial Pyk2 is expressed in two isoforms and associates with paxillin and p130Cas. Biochem Biophys Res Commun. 2002; 290(5):1470-7. DOI: 10.1006/bbrc.2002.6350. View

Nemeth Z, Deitch E, Lu Q, Szabo C, Hasko G . NHE blockade inhibits chemokine production and NF-kappaB activation in immunostimulated endothelial cells. Am J Physiol Cell Physiol. 2002; 283(2):C396-403. DOI: 10.1152/ajpcell.00491.2001. View

Maus U, Henning S, Wenschuh H, Mayer K, Seeger W, Lohmeyer J . Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow. Am J Physiol Heart Circ Physiol. 2002; 283(6):H2584-91. DOI: 10.1152/ajpheart.00349.2002. View

Madry H, Cucchiarini M, Terwilliger E, Trippel S . Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum Gene Ther. 2003; 14(4):393-402. DOI: 10.1089/104303403321208998. View

10.

Di Cioccio V, Strippoli R, Bizzarri C, Troiani G, Cervellera M, Gloaguen I . Key role of proline-rich tyrosine kinase 2 in interleukin-8 (CXCL8/IL-8)-mediated human neutrophil chemotaxis. Immunology. 2004; 111(4):407-15. PMC: 1782435. DOI: 10.1111/j.1365-2567.2004.01822.x. View

11.

Berman R, Frew J, Martin W . Endotoxin-induced arterial endothelial barrier dysfunction assessed by an in vitro model. Br J Pharmacol. 1993; 110(4):1282-4. PMC: 2175852. DOI: 10.1111/j.1476-5381.1993.tb13956.x. View

12.

Uguccioni M, DApuzzo M, Loetscher M, DEWALD B, Baggiolini M . Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol. 1995; 25(1):64-8. DOI: 10.1002/eji.1830250113. View

13.

Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio J . Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature. 1995; 376(6543):737-45. DOI: 10.1038/376737a0. View

14.

Kirkpatrick C, Klein C, Bittinger F . Pathobiology of the endothelium in multiple organ dysfunction syndrome. Contrib Nephrol. 1995; 116:1-9. DOI: 10.1159/000424604. View

15.

Astier A, Avraham H, Manie S, Groopman J, Canty T, Avraham S . The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas. J Biol Chem. 1997; 272(1):228-32. DOI: 10.1074/jbc.272.1.228. View

16.

Liu Z, Ganju R, Wang J, Ona M, Hatch W, Zheng T . Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J Clin Invest. 1997; 99(7):1798-804. PMC: 508001. DOI: 10.1172/JCI119344. View

17.

Baggiolini M, DEWALD B, Moser B . Human chemokines: an update. Annu Rev Immunol. 1997; 15:675-705. DOI: 10.1146/annurev.immunol.15.1.675. View

18.

Della Rocca G, van Biesen T, Daaka Y, Luttrell D, Luttrell L, Lefkowitz R . Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem. 1997; 272(31):19125-32. DOI: 10.1074/jbc.272.31.19125. View

19.

Rollins B . Chemokines. Blood. 1997; 90(3):909-28. View

20.

Gismondi A, Bisogno L, Mainiero F, Palmieri G, Piccoli M, Frati L . Proline-rich tyrosine kinase-2 activation by beta 1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J Immunol. 1997; 159(10):4729-36. View